AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to impose price controls for Botox. In a complaint ...
In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming price cuts under the Inflation Reduction Act (IRA), AbbVie is the latest to ...
The move is designed to keep the doors of the clinic open, and is a reflection of the increasingly blurred lines between the beauty industry and health care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results